USD 49.72
(0.0%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 4.92 Billion EUR | 48.15% |
2022 | 3.32 Billion EUR | 20.75% |
2021 | 2.75 Billion EUR | -12.7% |
2020 | 3.15 Billion EUR | -10.93% |
2019 | 3.54 Billion EUR | 12.18% |
2018 | 3.15 Billion EUR | 42.45% |
2017 | 2.21 Billion EUR | 60.15% |
2016 | 1.38 Billion EUR | -19.07% |
2015 | 1.71 Billion EUR | 140.77% |
2014 | 710.23 Million EUR | 3.82% |
2013 | 684.1 Million EUR | 57.22% |
2012 | 435.11 Million EUR | 0.1% |
2011 | 434.67 Million EUR | 57.08% |
2010 | 276.71 Million EUR | 130.56% |
2009 | 120.01 Million EUR | -58.58% |
2008 | 289.73 Million EUR | 694.23% |
2007 | 36.48 Million EUR | -38.21% |
2006 | 59.03 Million EUR | -41.82% |
2005 | 101.47 Million EUR | 59.65% |
2004 | 63.55 Million EUR | 38.25% |
2003 | 45.97 Million EUR | -10.69% |
2002 | 51.47 Million EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | 2.93 Billion EUR | 0.0% |
2023 Q4 | 4.92 Billion EUR | 0.0% |
2023 FY | 4.92 Billion EUR | 48.15% |
2023 Q2 | 3.27 Billion EUR | 0.0% |
2022 Q4 | 3.32 Billion EUR | 0.0% |
2022 Q2 | 3.34 Billion EUR | 0.0% |
2022 FY | 3.32 Billion EUR | 20.75% |
2021 Q2 | 2.65 Billion EUR | 0.0% |
2021 FY | 2.75 Billion EUR | -12.7% |
2021 Q4 | 2.75 Billion EUR | 0.0% |
2020 Q2 | 3.19 Billion EUR | 0.0% |
2020 FY | 3.15 Billion EUR | -10.93% |
2020 Q4 | 3.15 Billion EUR | 0.0% |
2019 Q4 | 3.54 Billion EUR | 0.0% |
2019 Q2 | 3.54 Billion EUR | 0.0% |
2019 FY | 3.54 Billion EUR | 12.18% |
2018 Q4 | 3.15 Billion EUR | 0.0% |
2018 FY | 3.15 Billion EUR | 42.45% |
2018 Q2 | 2.19 Billion EUR | 0.0% |
2017 Q2 | 1.33 Billion EUR | 0.0% |
2017 Q4 | 2.21 Billion EUR | 0.0% |
2017 FY | 2.21 Billion EUR | 60.15% |
2016 Q2 | 1.62 Billion EUR | 0.0% |
2016 Q4 | 1.38 Billion EUR | 0.0% |
2016 FY | 1.38 Billion EUR | -19.07% |
2015 Q2 | 1.15 Billion EUR | 0.0% |
2015 FY | 1.71 Billion EUR | 140.77% |
2015 Q4 | 1.71 Billion EUR | 0.0% |
2014 FY | 710.23 Million EUR | 3.82% |
2014 Q4 | 710.23 Million EUR | 0.0% |
2014 Q2 | 864.1 Million EUR | 0.0% |
2013 Q2 | 498.99 Million EUR | 0.0% |
2013 FY | 684.1 Million EUR | 57.22% |
2013 Q4 | 684.1 Million EUR | 0.0% |
2012 Q2 | 432.13 Million EUR | 0.0% |
2012 Q4 | 435.11 Million EUR | 0.0% |
2012 FY | 435.11 Million EUR | 0.1% |
2011 Q3 | 419.46 Million EUR | 19.13% |
2011 Q4 | 434.67 Million EUR | 3.63% |
2011 Q1 | 360.04 Million EUR | 30.11% |
2011 Q2 | 352.1 Million EUR | -2.2% |
2011 FY | 434.67 Million EUR | 57.08% |
2010 FY | 276.71 Million EUR | 130.56% |
2010 Q4 | 276.71 Million EUR | -8.38% |
2010 Q2 | 131.45 Million EUR | -44.8% |
2010 Q1 | 238.12 Million EUR | 98.41% |
2010 Q3 | 302.02 Million EUR | 129.75% |
2009 Q4 | 120.01 Million EUR | 0.0% |
2009 FY | 120.01 Million EUR | -58.58% |
2008 FY | 289.73 Million EUR | 694.23% |
2007 FY | 36.48 Million EUR | -38.21% |
2006 FY | 59.03 Million EUR | -41.82% |
2005 FY | 101.47 Million EUR | 59.65% |
2004 FY | 63.55 Million EUR | 38.25% |
2003 FY | 45.97 Million EUR | -10.69% |
2002 FY | 51.47 Million EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
American Bio Medica Corporation | 2.24 Million USD | -219841.964% |
Arrayit Corporation | 1.07 Million USD | -456851.474% |
Atlantic International Corp. | 2.93 Million USD | -168018.814% |
Biocept, Inc. | 12.1 Million USD | -40586.266% |
Bioqual, Inc. | 3.58 Million USD | -137249.334% |
CardioGenics Holdings Inc | 72.61 Thousand USD | -6784679.795% |
DermTech, Inc. | 54.39 Million USD | -8957.433% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | -944.083% |
HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -101818.763% |
iMD Companies, Inc. | 1.12 Million USD | -439725.416% |
IDenta Corp. | 789.14 Thousand USD | -624207.796% |
Interpace Biosciences, Inc. | 11.19 Million USD | -43919.836% |
Integrative Health Technologies, Inc. | - USD | -Infinity% |
InVitro International | 43.84 Thousand USD | -11236529.034% |
Lumos Diagnostics Holdings Limited | 8.04 Million USD | -61139.934% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 3.82 Million USD | -128672.652% |
NovelStem International Corp. | 3.57 Million USD | -137725.25% |
Optigenex Inc. | 8.94 Million USD | -55003.965% |
PharmChem, Inc. | 77.35 Thousand USD | -6369013.027% |
Proteome Sciences plc | 17.15 Million USD | -28620.959% |
Response Genetics, Inc | 6.37 Million USD | -77205.821% |
Rennova Health, Inc. | 15.32 Million USD | -32039.008% |
RushNet, Inc. | 4.82 Million USD | -102047.996% |
ScreenPro Security Inc. | 207.03 Thousand USD | -2379557.448% |
Stella Diagnostics Inc. | 6.2 Million USD | -79354.125% |
StageZero Life Sciences Ltd. | 1.8 Million USD | -273592.935% |
Todos Medical Ltd. | 38.34 Million USD | -12747.345% |